Cargando…
Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis
BACKGROUND: COVID-19 (Coronavirus Disease-2019) has spread widely around the world and impacted human health for millions. The lack of effective targeted drugs and vaccines forces scientific world to search for new effective antiviral therapeutic drugs. It has reported that flavonoids have potential...
Autores principales: | Xiao, Ting, Wei, Yuli, Cui, Mengqi, Li, Xiaohe, Ruan, Hao, Zhang, Liang, Bao, Jiali, Ren, Shanfa, Gao, Dandi, Wang, Ming, Sun, Ronghao, Li, Mingjiang, Lin, Jianping, Li, Dongmei, Yang, Cheng, Zhou, Honggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349562/ https://www.ncbi.nlm.nih.gov/pubmed/34419736 http://dx.doi.org/10.1016/j.phymed.2021.153704 |
Ejemplares similares
-
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation
por: Xiao, Ting, et al.
Publicado: (2021) -
Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting M(pro) and Sepsis in Mice
por: Xiao, Ting, et al.
Publicado: (2021) -
Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway
por: Yu, Rui, et al.
Publicado: (2023) -
The Versatile Effects of Dihydromyricetin in Health
por: Li, Hongliang, et al.
Publicado: (2017) -
Dihydromyricetin hexaacetate
por: Li, Wei, et al.
Publicado: (2010)